Loading...
XNAS
OPCH
Market cap5.02bUSD
Jul 14, Last price  
30.68USD
1D
2.68%
1Q
-4.90%
Jan 2017
2,850.00%
Name

Option Care Health Inc

Chart & Performance

D1W1MN
P/E
23.72
P/S
1.01
EPS
1.29
Div Yield, %
—
Shrs. gr., 5y
2.04%
Rev. gr., 5y
16.69%
Revenues
5.00b
+16.17%
1,073,235,0001,152,459,0001,197,732,0001,401,911,0001,329,525,0001,638,623,0001,818,026,000662,637,000842,195,000984,055,000982,223,000935,589,000817,190,000708,903,0002,310,417,0003,032,610,0003,438,640,0003,944,735,0004,302,324,0004,998,202,000
Net income
212m
-20.69%
-23,847,000-38,289,0003,317,000-74,032,00054,099,000-69,142,0007,872,00064,707,000-69,654,000-147,468,000-299,707,000-41,506,000-62,605,000-51,693,000-75,920,000-8,076,000139,898,000150,556,000267,090,000211,823,000
CFO
323m
-12.90%
-6,422,000-29,862,00024,187,000-8,746,00022,745,000-21,419,00026,969,00026,884,000-54,579,000-31,416,000-64,742,000-35,203,000-1,052,000-20,104,00039,467,000127,392,000208,569,000267,547,000371,295,000323,392,000
Earnings
Jul 29, 2025

Profile

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
URL
https://optioncarehealth.com/
IPO date
Aug 15, 1996
Employees
5,597
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,998,202
16.17%
4,302,324
9.06%
3,944,735
14.72%
Cost of revenue
3,985,209
3,321,101
3,077,817
Unusual Expense (Income)
NOPBT
1,012,993
981,223
866,918
NOPBT Margin
20.27%
22.81%
21.98%
Operating Taxes
71,776
91,652
55,212
Tax Rate
7.09%
9.34%
6.37%
NOPAT
941,217
889,571
811,706
Net income
211,823
-20.69%
267,090
77.40%
150,556
7.62%
Dividends
Dividend yield
Proceeds from repurchase of equity
(252,726)
(250,261)
BB yield
6.30%
4.12%
Debt
Debt current
50,600
42,556
25,380
Long-term debt
191,596
1,245,896
1,149,025
Deferred revenue
Other long-term liabilities
1,105,007
81,124
Net debt
(170,369)
913,520
843,477
Cash flow
Cash from operating activities
323,392
371,295
267,547
CAPEX
(41,866)
(35,358)
Cash from investing activities
(36,470)
(56,506)
(108,052)
Cash from financing activities
(218,206)
(265,126)
15,268
FCF
926,248
778,632
810,965
Balance
Cash
412,565
343,849
294,186
Long term investments
31,083
36,742
Excess cash
162,655
159,816
133,691
Stockholders' equity
680,401
472,509
211,600
Invested Capital
2,481,966
2,446,546
2,417,120
ROIC
38.19%
36.58%
35.00%
ROCE
37.63%
37.15%
33.69%
EV
Common stock shares outstanding
172,845
180,375
182,075
Price
23.20
-31.14%
33.69
11.96%
30.09
5.80%
Market cap
4,010,004
-34.01%
6,076,834
10.92%
5,478,637
6.31%
EV
3,839,635
6,990,354
6,322,114
EBITDA
1,076,491
1,043,423
932,352
EV/EBITDA
3.57
6.70
6.78
Interest
49,029
51,248
53,806
Interest/NOPBT
4.84%
5.22%
6.21%